Honokiol-Loaded Nanoemulsion for Glioblastoma Treatment: Statistical Optimization, Physicochemical Characterization, and an In Vitro Toxicity Assay

Background: Glioblastoma (GBM) is an extremely invasive and heterogenous malignant brain tumor. Despite advances in current anticancer therapy, treatment options for glioblastoma remain limited, and tumor recurrence is inevitable. Therefore, alternative therapies or new active compounds that can be...

Descripción completa

Detalles Bibliográficos
Autores principales: Gostyńska, Aleksandra, Czerniel, Joanna, Kuźmińska, Joanna, Brzozowski, Jakub, Majchrzak-Celińska, Aleksandra, Krajka-Kuźniak, Violetta, Stawny, Maciej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959519/
https://www.ncbi.nlm.nih.gov/pubmed/36839769
http://dx.doi.org/10.3390/pharmaceutics15020448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959519/
https://www.ncbi.nlm.nih.gov/pubmed/36839769
http://dx.doi.org/10.3390/pharmaceutics15020448

Ejemplares similares